These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 1372221)

  • 21. Mefloquine effect on disposition of halofantrine in the isolated perfused rat liver.
    Leo KU; Wesche DL; Marino MT; Brewer TG
    J Pharm Pharmacol; 1996 Jul; 48(7):723-8. PubMed ID: 8866337
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The in-vitro susceptibilities of Ghanaian Plasmodium falciparum to antimalarial drugs.
    Quashie NB; Duah NO; Abuaku B; Koram KA
    Ann Trop Med Parasitol; 2007 Jul; 101(5):391-8. PubMed ID: 17550644
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical efficacy and pharmacokinetics of micronized halofantrine for the treatment of acute uncomplicated falciparum malaria in nonimmune patients.
    Bouchaud O; Basco LK; Gillotin C; Gimenez F; Ramiliarisoa O; Genissel B; Bouvet E; Farinotti R; Le Bras J; Coulaud JP
    Am J Trop Med Hyg; 1994 Aug; 51(2):204-13. PubMed ID: 8074254
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antimalarial drug toxicity: a review.
    Taylor WR; White NJ
    Drug Saf; 2004; 27(1):25-61. PubMed ID: 14720085
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Trial of halofantrine in the treatment of malaria attacks by Plasmodium falciparum in Dakar (Senegal)].
    Diallo S; Gaye O; Bah IB; Trape JF; Konate L; Legros C; Dieng T; Faye O
    Bull Soc Pathol Exot; 1991; 84(3):298-303. PubMed ID: 1764759
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The treatment of malaria].
    Kager PA; Zijlmans CW; Boele van Hensbroek M; Wetsteyn JC
    Ned Tijdschr Geneeskd; 1997 Sep; 141(37):1774-8. PubMed ID: 9545726
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug-resistant malaria in Bangui, Central African Republic: an in vitro assessment.
    Menard D; Djalle D; Manirakiza A; Yapou F; Siadoua V; Sana S; Matsika-Claquin MD; Nestor M; Talarmin A
    Am J Trop Med Hyg; 2005 Aug; 73(2):239-43. PubMed ID: 16103582
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical trials with halofantrine hydrochloride in Malawi.
    Wirima J; Khoromana C; Molyneux ME; Gilles HM
    Lancet; 1988 Jul; 2(8605):250-2. PubMed ID: 2899238
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Epidemiological and therapeutic aspects of plasmodial infection from Plasmodium vivax].
    Nicolas X; Granier H; Martin J; Klotz F
    Med Trop (Mars); 2000; 60(4):402-8. PubMed ID: 11436600
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modulation of halofantrine resistance after coadministration of halofantrine with diverse pharmacological agents in a rodent malaria model.
    Singh N; Puri SK
    Life Sci; 2000 Aug; 67(11):1345-54. PubMed ID: 10972203
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics of an extended-dose halofantrine regimen in patients with malaria and in healthy volunteers.
    Ohrt C; Watt G; Teja-Isavadharm P; Keeratithakul D; Loesuttiviboon L; Webster HK; Schuster B; Fleckenstein L
    Clin Pharmacol Ther; 1995 May; 57(5):525-32. PubMed ID: 7768075
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Mechanisms and dynamics of drug resistance in Plasmodium falciparum].
    Le Bras J
    Bull Soc Pathol Exot; 1999; 92(4):236-41. PubMed ID: 10572658
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Efficacy of halofantrine in Plasmodium falciparum or Plasmodium vivax malaria in a resistance area (French Guiana)].
    Maisonneuve H; Joly F; John M; Carles G; Rossignol JF
    Presse Med; 1988 Jan; 17(3):99-102. PubMed ID: 2964606
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A randomised controlled trial to assess the relative efficacy of chloroquine, amodiaquine, halofantrine and Fansidar in the treatment of uncomplicated malaria in children.
    Anabwani GM; Esamai FO; Menya DA
    East Afr Med J; 1996 Mar; 73(3):155-8. PubMed ID: 8698011
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vivo efficacy of chloroquine, halofantrine, pyrimethamine-sulfadoxine and qinghaosu (artesunate) in the treatment of malaria in Calabar, Nigeria.
    Ezedinachi E
    Cent Afr J Med; 1996 Apr; 42(4):109-11. PubMed ID: 8791866
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Postexposure administration of halofantrine for the prevention of malaria.
    Shanks GD; Edstein MD; Kereu RK; Spicer PE; Rieckmann KH
    Clin Infect Dis; 1993 Oct; 17(4):628-31. PubMed ID: 8268342
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Malaria and drug resistance].
    Kager PA; Wetsteyn JC
    Ned Tijdschr Geneeskd; 1996 Jan; 140(3):151-5. PubMed ID: 8618636
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical experience with halofantrine in the treatment of malaria.
    Horton RJ; Parr SN; Bokor LC
    Drugs Exp Clin Res; 1990; 16(10):497-503. PubMed ID: 2100732
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Halofantrine in the treatment of acute uncomplicated falciparum malaria in the Philippines.
    Salazar NP; Carlos CC; Bustos DG; Quiambao BP; Saniel MC; Santos MN
    Southeast Asian J Trop Med Public Health; 1991 Sep; 22(3):386-92. PubMed ID: 1818390
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Response of falciparum malaria to different antimalarials in Myanmar.
    Ejov MN; Tun T; Aung S; Sein K
    Bull World Health Organ; 1999; 77(3):244-9. PubMed ID: 10212515
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.